{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:40:34Z","timestamp":1747154434319,"version":"3.40.5"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.advms.2024.04.007","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T15:55:36Z","timestamp":1714751736000},"page":"264-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The intriguing role of IL33\/ST2 axis signaling in oral diseases - A systematic review"],"prefix":"10.1016","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5626-2622","authenticated-orcid":false,"given":"Mala","family":"Kamboj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Keerthika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjali","family":"Narwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambika","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anju","family":"Devi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adarsh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gitika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.advms.2024.04.007_bib1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/10454411960070040101","article-title":"Keratinocytes and cytokine\/growth factors","volume":"7","author":"Feliciani","year":"1996","journal-title":"Crit Rev Oral Biol"},{"issue":"1","key":"10.1016\/j.advms.2024.04.007_bib2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/imr.12619","article-title":"Interleukin-33 (IL-33): a nuclear cytokine from the IL-1 family","volume":"281","author":"Cayrol","year":"2018","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.advms.2024.04.007_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-017-1021-4","article-title":"IL-33\/ST2 signaling contributes to radicular pain by modulating MAPK and NF-\u03baB activation and inflammatory mediator expression in the spinal cord in rat models of non-compressive lumbar disk herniation","volume":"15","author":"Huang","year":"2018","journal-title":"J\u00a0Neuroinflammation"},{"issue":"10","key":"10.1016\/j.advms.2024.04.007_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003331","article-title":"The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel \u2018alarmin\u2019?","volume":"3","author":"Moussion","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.advms.2024.04.007_bib5","first-page":"1","article-title":"Role of IL-33 in inflammation and disease","volume":"8","author":"Miller","year":"2011","journal-title":"J\u00a0Inflamm"},{"issue":"11","key":"10.1016\/j.advms.2024.04.007_bib6","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1002\/eji.201545501","article-title":"Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33","volume":"45","author":"Bandara","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.advms.2024.04.007_bib7","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3389\/fimmu.2017.00475","article-title":"The ST2\/IL-33 axis in immune cells during inflammatory diseases","volume":"8","author":"Griesenauer","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.advms.2024.04.007_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.156015","article-title":"IL-33\/ST2 axis in autoimmune disease","volume":"158","author":"Shakerian","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.advms.2024.04.007_bib9","article-title":"Preferred reporting Items for systematic reviews and Meta- analyses: the PRISMA statement","volume":"21","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.advms.2024.04.007_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cyto.2013.07.006","article-title":"Potential contribution of interleukin-33 to the development of interstitial lung disease in patients with primary Sjogren's Syndrome","volume":"64","author":"Zhao","year":"2013","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/j.advms.2024.04.007_bib11","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/annrheumdis-2012-203187","article-title":"Potential involvement of the IL-33\u2013ST2 axis in the pathogenesis of primary Sj\u00f6gren's syndrome","volume":"73","author":"Awada","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.advms.2024.04.007_bib12","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.anl.2014.08.007","article-title":"Expression of interleukin-33 is correlated with poor prognosis of patients with squamous cell carcinoma of the tongue","volume":"41","author":"Ishikawa","year":"2014","journal-title":"Auris Nasus Larynx"},{"issue":"7","key":"10.1016\/j.advms.2024.04.007_bib13","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1177\/0022034515577815","article-title":"IL-33 exacerbates periodontal disease through induction of RANKL","volume":"94","author":"Malcolm","year":"2015","journal-title":"J\u00a0Dent Res"},{"issue":"2","key":"10.1016\/j.advms.2024.04.007_bib14","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3899\/jrheum.140234","article-title":"The Interleukin 33\/ST2 axis in patients with primary Sj\u00f6gren syndrome: expression in serum and salivary glands, and the clinical association","volume":"42","author":"Jung","year":"2015","journal-title":"J\u00a0Rheumatol"},{"issue":"7","key":"10.1016\/j.advms.2024.04.007_bib15","first-page":"1295","article-title":"The IL33\/ST2 axis in Sjogren syndrome in relation to disease activity","volume":"20","author":"Margiotta","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.advms.2024.04.007_bib16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/jop.12312","article-title":"Expression of interleukin-33 and its receptor ST 2 in periapical granulomas and radicular cysts","volume":"45","author":"Velickovic","year":"2016","journal-title":"J\u00a0Oral Pathol Med"},{"key":"10.1016\/j.advms.2024.04.007_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/srep42413","article-title":"Interleukin-33 produced by M2 macrophages and other immune cells contributes to Th2 immune reaction of IgG4-related disease","volume":"7","author":"Furukawa","year":"2017","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.advms.2024.04.007_bib18","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1177\/1535370218774539","article-title":"Novel interleukin-33 and its soluble ST2 receptor as potential serum biomarkers in parotid gland tumors","volume":"243","author":"Pawel","year":"2018","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.advms.2024.04.007_bib19","article-title":"Downregulated miR-524-5p participates in the tumor microenvironment of ameloblastoma by targeting the interleukin-33 (IL-33)\/suppression of tumorigenicity 2 (ST2) axis","volume":"26","author":"Chen","year":"2020","journal-title":"Med. Sci. Monit."},{"issue":"1","key":"10.1016\/j.advms.2024.04.007_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4103\/ijdr.ijdr_85_21","article-title":"Evaluation of serum interleukin-33 and soluble suppression of tumorigenicity 2 (sST2) receptors in patients with and without periodontal disease","volume":"33","author":"Singh","year":"2022","journal-title":"Ind J Dent Res"},{"issue":"12","key":"10.1016\/j.advms.2024.04.007_bib21","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.4049\/jimmunol.2101070","article-title":"The IL-33\/ST2 Axis promotes primary Sj\u00f6gren\u2019s syndrome by enhancing salivary epithelial cell activation and type 1 immune response","volume":"208","author":"Dong","year":"2022","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.advms.2024.04.007_bib22","article-title":"Salivary IL-33 and sST2 levels in relation to TLR2 rs111200466 polymorphism and periodontitis","author":"Yilmaz","year":"2023","journal-title":"Oral Dis"},{"key":"10.1016\/j.advms.2024.04.007_bib23","article-title":"Neglected epidemics: the role of oral public health to advance global health","volume":"12","author":"Murtomaa","year":"2022","journal-title":"J\u00a0glob health"},{"issue":"3","key":"10.1016\/j.advms.2024.04.007_bib24","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/annrheumdis-2015-208557","article-title":"Pitfalls for detecting interleukin-33 by ELISA in the serum of patients with primary Sj\u00f6gren syndrome: comparison of different kits","volume":"75","author":"Riviere","year":"2016","journal-title":"Ann Rheum Dis"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112624000294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112624000294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T17:00:35Z","timestamp":1730739635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112624000294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1896112624000294"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2024.04.007","relation":{},"ISSN":["1896-1126"],"issn-type":[{"type":"print","value":"1896-1126"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The intriguing role of IL33\/ST2 axis signaling in oral diseases - A systematic review","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2024.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}